{"id":49165,"date":"2024-01-10T10:18:09","date_gmt":"2024-01-10T09:18:09","guid":{"rendered":"https:\/\/ticker-noticiasep.microcontenidos.com\/NoticiaRSS.vbhtml?user=XRNR562DLR&amp;cod=20240110101809"},"modified":"2024-01-10T10:18:09","modified_gmt":"2024-01-10T09:18:09","slug":"mundo-venatorx-pharmaceuticals-y-menarini-group-firman-un-acuerdo-comercial-para-cefepima-taniborbactam-2","status":"publish","type":"post","link":"https:\/\/webciudadana.net\/?p=49165","title":{"rendered":"Mundo: Venatorx Pharmaceuticals y Menarini Group firman un acuerdo comercial para cefepima-taniborbactam (2)"},"content":{"rendered":"\n<div><img decoding=\"async\" src=\"\/wp-content\/uploads\/sites\/2\/2024\/01\/mundo-venatorx-pharmaceuticals-y-menarini-group-firman-un-acuerdo-comercial-para-cefepima-taniborbactam-2.jpg\" class=\"ff-og-image-inserted\"><\/div>\n<p>(Informaci\u00f3n remitida por la empresa firmante)<\/p>\n<p>\nEste comunicado de prensa contiene declaraciones a futuro dentro del significado de la Ley de Reforma de Litigios sobre Valores Privados de 1995. Todas las declaraciones contenidas en este comunicado de prensa que no se relacionen con cuestiones de hechos hist\u00f3ricos deben considerarse declaraciones a futuro, incluidas, entre otras, declaraciones sobre el potencial, la seguridad, la eficacia y el desarrollo regulatorio y cl\u00ednico de los productos candidatos de Venatorx Pharmaceuticals. Logo &#8211; https:\/\/mma.prnewswire.com\/media\/2296569\/Menarini_Industrie_Farmaceutiche_Riunite_Logo.jpg<\/p>\n<p> View original content:https:\/\/www.prnewswire.com\/news-releases\/venatorx-pharmaceuticals-y-menarini-group-firman-un-acuerdo-comercial-para-cefepima-taniborbactam-302031046.html<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Informaci\u00f3n remitida por la empresa firmante) Este comunicado de prensa contiene declaraciones a futuro dentro del significado de la Ley de Reforma de Litigios sobre Valores Privados de 1995. Todas las declaraciones contenidas en este comunicado de prensa que no se relacionen con cuestiones de hechos hist\u00f3ricos deben considerarse declaraciones a futuro, incluidas, entre otras, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-49165","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/posts\/49165","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=49165"}],"version-history":[{"count":0,"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/posts\/49165\/revisions"}],"wp:attachment":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=49165"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=49165"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=49165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}